Maurus de la Rosa

2.8k total citations · 1 hit paper
19 papers, 2.2k citations indexed

About

Maurus de la Rosa is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Maurus de la Rosa has authored 19 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 8 papers in Genetics. Recurrent topics in Maurus de la Rosa's work include CAR-T cell therapy research (9 papers), Virus-based gene therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Maurus de la Rosa is often cited by papers focused on CAR-T cell therapy research (9 papers), Virus-based gene therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Maurus de la Rosa collaborates with scholars based in Germany, United States and Austria. Maurus de la Rosa's co-authors include Alexander Scheffold, Sascha Rutz, Alf Hamann, Joachim Lehmann, Jochen Huehn, Birgit M. Reipert, Monika C. Brunner‐Weinzierl, Veit Krenn, Friedrich Scheiflinger and Kevin Thurley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Maurus de la Rosa

18 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cells

2004 520 citations Jochen Huehn, Kerstin Siegmund et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maurus de la Rosa Germany	13	1.5k	415	410	388	172	19	2.2k
François M. Lemoine France	24	971 0.6×	639 1.5×	553 1.3×	335 0.9×	164 1.0×	58	1.8k
Marc‐André Wurbel United States	18	1.9k 1.2×	567 1.4×	540 1.3×	208 0.5×	96 0.6×	22	2.4k
Raymond J. Steptoe Australia	32	2.8k 1.8×	659 1.6×	547 1.3×	423 1.1×	132 0.8×	90	3.8k
José R. Regueiro Spain	25	1.4k 0.9×	366 0.9×	386 0.9×	251 0.6×	189 1.1×	108	2.0k
Roli Khattri United States	11	3.3k 2.1×	348 0.8×	703 1.7×	384 1.0×	102 0.6×	14	3.7k
Megan Barnden Australia	14	1.9k 1.3×	467 1.1×	376 0.9×	155 0.4×	83 0.5×	15	2.4k
Hilary S. Warren Australia	24	1.9k 1.3×	506 1.2×	380 0.9×	220 0.6×	171 1.0×	66	2.7k
Noriko Arase Japan	20	1.9k 1.3×	402 1.0×	395 1.0×	166 0.4×	164 1.0×	53	2.5k
Federica Pericle United States	27	1.2k 0.8×	557 1.3×	595 1.5×	272 0.7×	63 0.4×	42	1.9k
Florentina Marches United States	17	1.0k 0.7×	378 0.9×	559 1.4×	149 0.4×	97 0.6×	29	1.8k

Countries citing papers authored by Maurus de la Rosa

Since Specialization

Citations

This map shows the geographic impact of Maurus de la Rosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurus de la Rosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurus de la Rosa more than expected).

Fields of papers citing papers by Maurus de la Rosa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurus de la Rosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurus de la Rosa. The network helps show where Maurus de la Rosa may publish in the future.

Co-authorship network of co-authors of Maurus de la Rosa

This figure shows the co-authorship network connecting the top 25 collaborators of Maurus de la Rosa. A scholar is included among the top collaborators of Maurus de la Rosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurus de la Rosa. Maurus de la Rosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

David, Marion, Davide Monteferrario, Satish K. Tadi, et al.. (2025). Enhanced anti-tumor activity by zinc finger repressor-driven epigenetic silencing of immune checkpoints and TGFBR2 in CAR-T cells and TILs. PubMed. 33(2). 200989–200989. 1 indexed citations

David, Marion, Yue Cui, Emma Proïcs, et al.. (2024). MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis. Journal of Neuroinflammation. 21(1). 268–268. 15 indexed citations

Monteferrario, Davide, Marion David, Satish K. Tadi, et al.. (2024). Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays. Molecular Therapy — Methods & Clinical Development. 32(2). 101255–101255. 2 indexed citations

David, Marion, et al.. (2023). Production of therapeutic levels of human FIX-R338L by engineered B cells using GMP-compatible medium. Molecular Therapy — Methods & Clinical Development. 31. 101111–101111. 3 indexed citations

Konkle, Barbara A., Christopher Walsh, Miguel A. Escobar, et al.. (2020). BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression. Blood. 137(6). 763–774. 138 indexed citations

Frentsch, Marco, Alberto Sada Japp, Manuela Dingeldey, et al.. (2020). Blockade of the costimulatory CD28‐B7 family signal axis enables repeated application of AAV8 gene vectors. Journal of Thrombosis and Haemostasis. 18(5). 1075–1080. 12 indexed citations

Tang, Ying, et al.. (2019). Co-Prevalence of Pre-Existing Immunity to Different Serotypes of Adeno-Associated Virus (AAV) in Adults with Hemophilia. Blood. 134(Supplement_1). 3349–3349. 10 indexed citations

Koppensteiner, Herwig, Bettina Hartlieb, Sebastian Dörn, et al.. (2019). Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays. Human Gene Therapy Methods. 30(2). 35–43. 25 indexed citations

Hartlieb, Bettina, Sebastian Dörn, Herwig Koppensteiner, et al.. (2019). Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors. Molecular Therapy — Methods & Clinical Development. 14. 126–133. 137 indexed citations

10.

Weiller, Markus, et al.. (2019). AAV8-Specific Immune Adsorption Column: A Treatment Option for Patients with Pre-Existing Anti-AAV8 Neutralizing Antibodies. Blood. 134(Supplement_1). 5922–5922.

11.

Keating, Sheila M., John W. Heitman, Shiquan Wu, et al.. (2016). Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates. Journal of Virology. 90(22). 10339–10350. 23 indexed citations

12.

Allacher, Peter, Maurus de la Rosa, Alexander Bauer, et al.. (2016). The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?. Pharmaceutical Research. 33(9). 2239–2249. 136 indexed citations

13.

Schuster, Maria, Markus Weiller, Gerhard Antoine, et al.. (2013). Development of a Transgenic Mouse Model with Immune Tolerance for Human Coagulation Factor VIIa. Pharmaceutical Research. 30(11). 2855–2867. 2 indexed citations

14.

Helden, Pauline M. van, David C. Wraith, Corinna Hermann, et al.. (2012). CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice. Blood. 119(17). 4073–4082. 65 indexed citations

15.

Busse, Dorothea, Maurus de la Rosa, Kevin Thurley, et al.. (2010). Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proceedings of the National Academy of Sciences. 107(7). 3058–3063. 223 indexed citations

16.

Brandenburg, Susan, Takeshi Takahashi, Maurus de la Rosa, et al.. (2008). IL‐2 induces in vivo suppression by CD4⁺CD25⁺Foxp3⁺ regulatory T cells. European Journal of Immunology. 38(6). 1643–1653. 92 indexed citations

17.

Rosa, Maurus de la, et al.. (2004). Interleukin‐2 is essential for CD4⁺CD25⁺ regulatory T cell function. European Journal of Immunology. 34(9). 2480–2488. 415 indexed citations

18.

Huehn, Jochen, Kerstin Siegmund, Joachim Lehmann, et al.. (2004). Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cells. The Journal of Experimental Medicine. 199(3). 303–313. 520 indexed citations breakdown →

19.

Lehmann, Joachim, Jochen Huehn, Maurus de la Rosa, et al.. (2002). Expression of the integrin α_Eβ₇identifies unique subsets of CD25⁺as well as CD25⁻regulatory T cells. Proceedings of the National Academy of Sciences. 99(20). 13031–13036. 398 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact